Clinical Trial Update: Safety and Acceptability of a Vaginal Microbicide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and acceptability of a vaginal microbicide for HIV infections, hepatitis B, and chronic conditions; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Hepatitis B

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Hepatitis B, Chronic | Phase 2 | Status: COMPLETED